About Atomoxetine Hydrochloride API
Therapeutic Category Central Nervous System (CNS)
CAS Number
82248-59-7
API Technology
Synthetic
Dose Form
Tablets
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, Canada DMF
Mechanism of Action
The precise mechanism by which atomoxetine produces its therapeutic effects in Attention-Deficit/Hyperactivity Disorder (ADHD) is unknown, but is thought to be related to selective inhibition of the pre-synaptic norepinephrine transporter, as determined in ex vivo uptake and neurotransmitter depletion studies.
Indication
STRATTERA is a selective norepinephrine reuptake inhibitor indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Related APIs
Edaravone
Central Nervous System (CNS)
Fluoxetine
Central Nervous System (CNS)
Levetiracetam
Central Nervous System (CNS)
Memantine Hydrochloride
Central Nervous System (CNS)
Xanomeline
Central Nervous System (CNS)
Eslicarbazepine Acetate
Central Nervous System (CNS)
Lumateperone Tosylate
Central Nervous System (CNS)
Lurasidone Hydrochloride
Central Nervous System (CNS)
Donepezil Hydrochloride
Central Nervous System (CNS)
Eszopiclone
Central Nervous System (CNS)
Dimethyl Fumarate
Central Nervous System (CNS)
Ropinirole
Central Nervous System (CNS)
Olanzapine (Form 1)
Central Nervous System (CNS)
Atomoxetine Hydrochloride
Central Nervous System (CNS)
Ziprasidone Hydrochloride Anhydrous
Central Nervous System (CNS)
Tizanidine Hydrochloride
Central Nervous System (CNS)
Sugammadex Sodium
Central Nervous System (CNS)
Benzatropine Mesylate
Central Nervous System (CNS)
Siponimod Hemifumarate
Central Nervous System (CNS)
Rivastigmine Hydrogen Tartrate
Central Nervous System (CNS)
Risperidone
Central Nervous System (CNS)
Quetiapine Fumarate
Central Nervous System (CNS)
Pregabalin
Central Nervous System (CNS)
FAQs
Treats attention deficit hyperactivity disorder (ADHD) by increasing attention and reducing hyperactivity and impulsiveness
-
It is a oncology product used to treat Metastatic castration-resistant prostate cancer (CRPC). Metastatic high-risk castration-sensitive prostate cancer (CSPC)
-
Available as oral capsules: 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg
-
Store at 20°C to 25°C (68°F to 77°F), in a tightly closed container, protect from moisture